158 related articles for article (PubMed ID: 35932377)
1. Dedifferentiation in low-grade osteosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study.
Hirai T; Kobayashi H; Kobayashi E; Saito M; Akiyama T; Kikuta K; Nakai T; Endo M; Tsukamoto S; Hakozaki M; Takenaka S; Nishimura S; Kawashima H; Tanzawa Y; Kawano H; Tanaka S
Int J Clin Oncol; 2022 Nov; 27(11):1758-1766. PubMed ID: 35932377
[TBL] [Abstract][Full Text] [Related]
2. A clinical comparison between dedifferentiated low-grade osteosarcoma and conventional osteosarcoma.
Toki S; Kobayashi E; Yoshida A; Ogura K; Wakai S; Yoshimoto S; Yonemori K; Kawai A
Bone Joint J; 2019 Jun; 101-B(6):745-752. PubMed ID: 31154837
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic challenges in low-grade central osteosarcoma.
Khal AA; Aiba H; Righi A; Gambarotti M; Atherley O'Meally AO; Manfrini M; Donati DM; Errani C
Bone Joint J; 2024 Jan; 106-B(1):99-106. PubMed ID: 38160683
[TBL] [Abstract][Full Text] [Related]
4. Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?
Tsuda Y; Tsoi K; Stevenson JD; Parry MC; Fujiwara T; Sumathi V; Jeys LM
Clin Orthop Relat Res; 2020 Jun; 478(6):1190-1198. PubMed ID: 31904683
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
Xu J; Xie L; Guo W
Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
[TBL] [Abstract][Full Text] [Related]
6. Dedifferentiated high-grade osteosarcoma originating from low-grade central osteosarcoma of the fibula.
Kenan S; Ginat DT; Steiner GC
Skeletal Radiol; 2007 Apr; 36(4):347-51. PubMed ID: 16816966
[TBL] [Abstract][Full Text] [Related]
7. Conventional and dedifferentiated parosteal osteosarcoma. Diagnosis, treatment, and outcome.
Sheth DS; Yasko AW; Raymond AK; Ayala AG; Carrasco CH; Benjamin RS; Jaffe N; Murray JA
Cancer; 1996 Nov; 78(10):2136-45. PubMed ID: 8918422
[TBL] [Abstract][Full Text] [Related]
8. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute.
Bertoni F; Bacchini P; Staals EL; Davidovitz P
Cancer; 2005 Jun; 103(11):2373-82. PubMed ID: 15852358
[TBL] [Abstract][Full Text] [Related]
9. Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi-institutional study.
Ogura K; Fujiwara T; Yasunaga H; Matsui H; Jeon DG; Cho WH; Hiraga H; Ishii T; Yonemoto T; Kamoda H; Ozaki T; Kozawa E; Nishida Y; Morioka H; Hiruma T; Kakunaga S; Ueda T; Tsuda Y; Kawano H; Kawai A
Cancer; 2015 Nov; 121(21):3844-52. PubMed ID: 26194185
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcomas after the age of 50: a clinicopathologic study of 64 cases--an experience in northern Japan.
Okada K; Hasegawa T; Nishida J; Ogose A; Tajino T; Osanai T; Yanagisawa M; Hatori M
Ann Surg Oncol; 2004 Nov; 11(11):998-1004. PubMed ID: 15525829
[TBL] [Abstract][Full Text] [Related]
11. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
12. Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma.
Tsuda Y; Tsoi K; Parry MC; Stevenson JD; Fujiwara T; Sumathi V; Jeys LM
Bone Joint J; 2020 Jun; 102-B(6):795-803. PubMed ID: 32475245
[TBL] [Abstract][Full Text] [Related]
13. Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.
Iwamoto Y; Tanaka K; Isu K; Kawai A; Tatezaki S; Ishii T; Kushida K; Beppu Y; Usui M; Tateishi A; Furuse K; Minamizaki T; Kawaguchi N; Yamawaki S
J Orthop Sci; 2009 Jul; 14(4):397-404. PubMed ID: 19662473
[TBL] [Abstract][Full Text] [Related]
14. [Preoperative adjuvant therapy for primary malignant bone tumors].
Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis.
Rossi B; Schinzari G; Maccauro G; Scaramuzzo L; Signorelli D; Rosa MA; Fabbriciani C; Carlo B
BMC Musculoskelet Disord; 2010 Feb; 11():34. PubMed ID: 20158913
[TBL] [Abstract][Full Text] [Related]
16. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
17. Parosteal osteosarcoma of the distal ulna. A rare tumour at a rare location: a case report.
Drinkuth S; Segmüller H; Furrer M; von Wartburg U
Chir Main; 2003 Apr; 22(2):104-8. PubMed ID: 12822246
[TBL] [Abstract][Full Text] [Related]
18. Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma.
Aung L; Gorlick R; Healey JH; Shi W; Thaler HT; Shorter NA; Huvos AG; Meyers PA
J Clin Oncol; 2003 Jan; 21(2):342-8. PubMed ID: 12525528
[TBL] [Abstract][Full Text] [Related]
19. Location of residual viable tumor cells after neoadjuvant chemotherapy: A new concept with high prognostic performance in osteosarcoma.
Kim SH; Shin KH; Moon SH; Kong Y; Suh JS; Yang WI
J Surg Oncol; 2017 May; 115(6):752-759. PubMed ID: 28403564
[TBL] [Abstract][Full Text] [Related]
20. DNA cytometry of osteosarcoma.
Bauer HC
Acta Orthop Scand Suppl; 1988; 228():1-39. PubMed ID: 3063059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
